Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt- -catenin-mediated intestinal tumor growth and regeneration
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt- -catenin-mediated intestinal tumor growth and regeneration
Authors
Keywords
-
Journal
Science Signaling
Volume 7, Issue 345, Pages ra92-ra92
Publisher
American Association for the Advancement of Science (AAAS)
Online
2014-10-01
DOI
10.1126/scisignal.2005411
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insights into the Role of STAT3 in Human Lymphocyte Differentiation as Revealed by the Hyper-IgE Syndrome
- (2014) S. G. Tangye et al. JOURNAL OF IMMUNOLOGY
- Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
- (2013) Tracy L. Putoczki et al. CANCER CELL
- A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth
- (2013) T. Lau et al. CANCER RESEARCH
- The Intestinal Crypt, A Prototype Stem Cell Compartment
- (2013) Hans Clevers CELL
- Development of PI3K inhibitors: lessons learned from early clinical trials
- (2013) Jordi Rodon et al. Nature Reviews Clinical Oncology
- Overexpression of BMI-1 is associated with poor prognosis in cervical cancer
- (2012) Yong-Qing Tong et al. Asia-Pacific Journal of Clinical Oncology
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties
- (2012) Sarah Schwitalla et al. CELL
- Bmi-1 Promotes the Chemoresistance, Invasion and Tumorigenesis of Pancreatic Cancer Cells
- (2012) Tao Yin et al. CHEMOTHERAPY
- Non-autonomous crosstalk between the Jak/Stat and Egfr pathways mediates Apc1-driven intestinal stem cell hyperplasia in the Drosophila adult midgut
- (2012) J. B. Cordero et al. DEVELOPMENT
- A phase II study of RO4929097 in metastatic colorectal cancer
- (2012) Jonathan R. Strosberg et al. EUROPEAN JOURNAL OF CANCER
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
- (2012) Andrew Jarnicki et al. Cell Division
- Absolute requirement for STAT3 function in small-intestine crypt stem cell survival
- (2011) J R Matthews et al. CELL DEATH AND DIFFERENTIATION
- STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers
- (2011) Teppei Morikawa et al. CLINICAL CANCER RESEARCH
- Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
- (2011) Wim de Lau et al. NATURE
- A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics
- (2010) Yi Hong et al. CLINICAL & EXPERIMENTAL METASTASIS
- Focal Adhesion Kinase Is Required for Intestinal Regeneration and Tumorigenesis Downstream of Wnt/c-Myc Signaling
- (2010) Gabrielle H. Ashton et al. DEVELOPMENTAL CELL
- p21 loss blocks senescence following Apc loss and provokes tumourigenesis in the renal but not the intestinal epithelium
- (2010) Alicia M. Cole et al. EMBO Molecular Medicine
- Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts
- (2010) Toshiro Sato et al. NATURE
- Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability
- (2010) Magdalena Skrzypczak et al. PLoS One
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice
- (2009) Monica Musteanu et al. GASTROENTEROLOGY
- Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer
- (2009) Da-wei Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Polycomb group protein Bmi1 expression in colon cancers predicts the survival
- (2009) Jianjun Du et al. MEDICAL ONCOLOGY
- Prediction and Experimental Validation of Novel STAT3 Target Genes in Human Cancer Cells
- (2009) Young Min Oh et al. PLoS One
- Genome-wide discovery of functional transcription factor binding sites by comparative genomics: The case of Stat3
- (2009) F. Vallania et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Replication Stalling Attenuates Tyrosine Kinase Signaling to Suppress S Phase Progression
- (2008) Ben J. Shields et al. CANCER CELL
- Deficiency of Mbd2 Attenuates Wnt Signaling
- (2008) T. J. Phesse et al. MOLECULAR AND CELLULAR BIOLOGY
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
- Crypt stem cells as the cells-of-origin of intestinal cancer
- (2008) Nick Barker et al. NATURE
- Bmi1 is expressed in vivo in intestinal stem cells
- (2008) Eugenio Sangiorgi et al. NATURE GENETICS
- Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc 716 mice
- (2008) T. Fujishita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search